Financial Daily from THE HINDU group of publications
Tuesday, Aug 09, 2005


News
Features
Stocks
Port Info
Archives
Google

Group Sites

Home Page - Regulatory Bodies & Rulings
Marketing - Standards & Benchmarks


J&J can keep the `baby', but with a caution!

P.T. Jyothi Datta

Mumbai , Aug. 8

JOHNSON & Johnson (J&J) can keep the `baby' reference, but it will have to drop any health claims from its label.

The multinational company will also have to carry a caution label, besides a list of ingredients on its package, the Maharastra Food and Drug Administration (FDA) has said in its recent order on the baby-oil controversy.

The company has been given time till September to clear out existing inventory and incorporate the new labelling requirements on its packages, the FDA Commissioner, Mr Ramesh Kumar, told Business Line.

Bringing the curtains down on a five-month old controversy, the FDA order has asked J&J to carry caution labels on "all baby cosmetic products". The company's baby oil had been called into question, as the base was light liquid paraffin oil, a mineral oil believed to be unfit for babies.

J&J's baby oil and hair-oil will now carry the caution: "For external use only. Keep out of reach of children to avoid accidental drinking and inhalation, which can cause injury. Discontinue use if skin irritation occurs."

Meanwhile, seven other J&J products including baby cream, lotion, baby-milk, shampoo, nourishing-soap, blossoms and milk-soap will carry a smaller warning, also indicating that the product be discontinued is skin irritation continues, the FDA order said.

The warning is important from a user point of view, as the issue first came to the fore on a consumer complaint that the baby-oil had resulted in allergy.

J&J has also been asked to give a toll-free number on its package, in case of consumer queries.

A spokesperson for J&J indicated that the labelling changes will be made by September. The new labels have also been sent to the Drug Controller General of India. Significantly, the baby-oil controversy is one of the reasons that precipitated a change in the Drugs and Cosmetics Act 1940. Changes are now being made to tighten the labelling of cosmetics, across the board.

Following J&J's baby oil, similar products from Wipro, Himalaya, Emami and Dabur had also been put under the scanner.

The FDA chief said that Wipro has already agreed to change its label and have a detailed ingredients list. As for Emami and Dabur, he said there has been a lull in the proceedings. Dabur's oil was being imported from Nepal. These products had ayurvedic ingredients, he said. He indicated that there were more issues here to be sorted out, before a final order is given on these products.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


TMB Ltd

Stories in this Section
Monsoon extends `above normal' performance into early August


Bharti outsources call centre operations — Signs Rs 1000-cr deal with 4 BPOs
Purchase of petro products for retail sale — Oil marketing chiefs to meet today for better deal from pvt refiners
One-day matches featuring India — DD can obtain rights from sports broadcasters
Prasar Bharati, Ten Sports fail to reach pact for finals
Sensex sheds 148 points on weak global markets
3 Malaysian cos join race for 49% stake in Nagarjuna Power project
Compliance with revised Clause 49 — SEBI must clarify scope of internal control, say experts
J&J can keep the `baby', but with a caution!


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line